Wednesday, AgPlenus Ltd., a subsidiary of Evogene Ltd. (EVGN), announced a licensing and collaboration agreement with Bayer AG (BAYZF.PK,BAYRY.PK,BYR.L) to develop a sustainable Mode-of-Action broad-spectrum herbicide for farmers.
This collaboration aims to leverage artificial intelligence to improve crop protection chemistry by utilizing AI-driven computational modeling technology to enhance and create molecules that can target the APTH1 protein, a new mode of action identified by AgPlenus.
The partnership is expected to benefit from AgPlenus' exclusive computational technology, supported by Evogene's ChemPass AI tech engine, and Bayer's extensive experience in the research, development, and marketing of crop protection solutions.
Bayer will hold the exclusive rights to develop and commercialize products resulting from the collaboration, while AgPlenus will receive an initial payment, continuous research funding, milestone payments, and royalties based on future product sales.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.